Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000964590 | SCV001111812 | likely benign | Epileptic encephalopathy | 2025-01-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004917660 | SCV005586557 | uncertain significance | not specified | 2024-09-26 | criteria provided, single submitter | clinical testing | The c.1774G>A (p.G592S) alteration is located in exon 11 (coding exon 10) of the FASN gene. This alteration results from a G to A substitution at nucleotide position 1774, causing the glycine (G) at amino acid position 592 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |